Corticosteroids: Potential β2-agonist and anticholinergic interactions in chronic obstructive pulmonary disease

Proceedings of the American Thoracic Society

Volumn 2, Issue 4, 2005, Pages 320-325

  Johnson, Malcolm ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

2 receptors; Combination therapy; Muscarinic receptors

Indexed keywords

ACETYLCHOLINE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; FLUTICASONE PROPIONATE; FORMOTEROL; IPRATROPIUM BROMIDE; ISOPRENALINE; METHYLPREDNISOLONE; MUSCARINIC M2 RECEPTOR; SALMETEROL; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; GLUCOCORTICOID RECEPTOR; MUSCARINIC RECEPTOR;

BACTERIAL INFECTION; BREATHING MUSCLE; CELL PROTECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CYTOKINE RELEASE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; LUNG ALVEOLUS MACROPHAGE; MUCUS GLAND; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE; VIRUS INFECTION; ANIMAL; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; METABOLISM; REVIEW;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANIMALS; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MUSCARINIC;

EID: 27644512848     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200504-040SR     Document Type: Conference Paper

References (56)

1. Lucchesi PA, Scheid CR, Romano FD, Kargacin ME, Mullikin-Kilpatrick D, Yamaguchi H, Honeyman TW. Ligand binding and G protein coupling of muscarinic receptors in airway smooth muscle. Am J Physiol 1990;258:C730-C738.
2. 2 receptors in cultured human airway smooth muscle cells. Am J Respir Cell Mol Biol 1993;9:541-546.
3. Gerthoffer WT. Regulation of the contractile element of airway smooth muscle. Am J Physiol 1991;261:L15-L28.
4. Gunst SJ, Stropp JQ, Flavahan NA. Muscarinic receptor reserve and β-adrenergic sensitivity in tracheal smooth muscle. J Appl Physiol 1989;67:1294-1298.
5. Madison JM. Muscarinic receptor reserve of airway smooth muscle and the response to isoproterenol. J Appl Physiol 1990;68:1017-1023.
6. Fryer AD, Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1984;84:973-978.
7. Minette P, Barnes PJ. Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea-pig airways. J Appl Physiol 1988;64:2532-2537.
8. Barnes PJ. Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol 1997;1:159-168.
9. Adcock IM, Ito K. Molecular mechanisms of corticosteroid actions. Monaldi Arch Chest Dis 2000;55:256-266.
10. Emala CW, Clancy J, Hirshman CA. Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle. Am J Physiol 1997;272:L745-L751.
11. Nabishah BM, Moral PB, Kadir BA, Khalid BAK. Effect of steroid hormones on muscarinic receptors of bronchial smooth muscle. Gen Pharmacol 1991;22:389-392.
12. 2 muscarinic receptor expression and function in the airways. Am J Respir Cell Mol Biol 2001;24:485-491.
13. Scherrer D, Lach E, Landry Y, Gies JP. Glucocorticoid modulation of muscarinic and beta-adrenergic receptors in guinea pig lung. Fundam Clin Pharmacol 1997;11:111-116.
14. Moreno L, Jacoby DB, Fryer AD. Dexamethasone prevents virus-induced hyperresponsiveness via multiple mechanisms. Am J Physiol Lung Cell Mol Physiol 2003;285:L451-L455.
15. Evans CM, Jacoby DB, Fryer AD. Effect of dexamethasone on antigen-induced airway eosinophilia and M(2) receptor dysfunction. Am J Respir Crit Care Med 2001:163:1484-1492.
16. Muma NA, Beck SG. Corticosteroids alter G protein inwardly rectifying potassium channels protein levels in hippocampal sub-fields. Brain Res 1999;839:331-335.
17. Nabishah BM, Moral PB, Khalid BA, Kadir BA. Effect of acetylcholine and morphine on bronchial smooth muscle contraction and its modulation by steroid hormones. Clin Exp Pharmacol Physiol 1999;17:841-847.
18. 2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus. Am J Physiol Lung Cell Mol Physiol 2002;283:L1125-L1132.
19. 2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J Pharmacol Exp Ther 1992;262:119-126.
20. 2-adrenoceptor. Am J Respir Crit Care Med 1998;158:S146-S153.
21. 2- adrenoceptor agonists. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Boston: Blackwell Scientific Publications; 1995. pp. 1278-1295.
22. 2-adrenergic receptor to different G-proteins by protein kinase A. Nature 1997;390:88-91.
23. 2-adrenergic receptor transcription in human lung. Am J Physiol 1995;268: L41-L46.
24. 2- adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med 1997;155:704-710.
25. 2-bronchodilators. Eur J Clin Pharmacol 1988;34:145-150.
26. 2- adrenergic receptors in vivo. J Clin Invest 1995;96:99-106.
27. Koto HM, Mak JC, Haddad CD, Xu WB, Salmon M, Barnes PJ, Chung KF. Mechanisms of impaired beta-adrenoceptor-induced airway relaxation by interleukin-1 beta in vivo in the rat. J Clin Invest 1996;98:1789-1797.
28. 2-agonists and corticosteroids. Current Allergy & Clin Immunol 2002;15:16-22.
29. 2-agonists. J Allergy Clin Immunol 2002;110:S261-8268.
30. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999;274:1005-1010.
31. Roth M, Rudiger J, Bihl M, Leufgen H, Cornelius B, Genacy M, Soler M, Perruchoud AP, Tamm M. The beta-2-agonist formoterol activates the glucocorticoid receptor in vivo. Eur Respir J 2000;16:437S.
32. Roth M, Johnson PR, Rudiger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, Black JL. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronized cellular signaling. Lancet 2002;360:1293-1299.
33. 2 agonists and glucocorticoids. Eur Respir J 2004;24:483S.
34. Usmani O, Maneechotesuwan K, Adcock I, Barnes P. Glucocorticoid receptor activation following inhaled fluticasone and salmeterol. Am J Respir Crit Care Med 2002;165:A616.
35. 2-agonists in vivo: a double blind crossover study. Am J Respir Crit Care Med 2002;165:A618.
36. Edwards M, Johnson M, Johnson S. Synergistic effects of salmeterol and fluticasone in human rhinovirus induced pro-inflammatory cytokine production. Am J Respir Crit Care Med 2003;167:A399.
37. 2- agonists and corticosteroids on TNFα-induced interleukin 8 release from cultured human airway smooth muscle cells. Am J Respir Cell Mol Biol 2000;22:1-7.
38. Sarir H, Mortaz E, Nijkamp FP, Folkerts G. Cigarette-smoke induced IL8 production by human monocyte-derived macrophages: synergistic inhibition by fluticasone and salmeterol. Eur Respir J 2005;26:145.
39. Seeto L, Johnson M, Hendel N, Lim S. Effect of dexamethasone and salmeterol on alveolar macrophage cytokine production in patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2002;165:A597.
40. Dowling RB, Johnson M, Cole PJ, Wilson R. Effect of fluticasone propionate (FP) and salmeterol (SM) on P.aeruginosa (PA) infection of respiratory mucosa in vitro. Am J Respir Crit Care Med 1998;157:A138.
41. de Bentzmann S, Kiletzky C, Hinnrasky J, Zahm J, Puchelle E. Salmeterol protects airway epithelium from bacterial injury by preventing tight junction degradation. Am J Respir Crit Care Med 2002;165:A652.
42. Wempe JB, Postma DS, Breederveld N, Kort E, van der Mark TW, Koëter GH. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease. Thorax 1992;47:616-621.
43. Hodder RV, White RJ, Menjoge SS, Kesten S. Effectiveness of tiotropium or salmeterol in COPD patients receiving inhaled steroids. Am J Respir Crit Care Med 2002;165:A228.
44. Dragoslav V, Stankovic IJ, Pejcic TA, Rancic MH, Ristic LM, Radovic MM. Comparative study of two years treatment with Salmeterol alone and in combination with ipratropium bromide & beclomethasone dipropionate in patients with COPD. Eur Respir J 2004;24:342S.
45. Barnes NC, Qiu Y, Pavord I, Parker D, Johnson M, Thomson N, Jeffery PK. Salmeterol/fluticasone propionate (SFC): Anti-inflammatory effects in COPD [abstract]. Proc Am Thorac Soc 2005;2:A543.
46. Hattotuwa KL, Gizycki M, Ansari TW, Gizycki M, Jeffery PK, Barnes NC. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind placebo-controlled biopsy study. Am J Respir Crit Care Med 2002;165:1592-1596.
47. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson G, Maden C. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361:449-456.
48. Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olson H. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003;21:74-81.
49. Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002;20:819-825.
50. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184-3188.
51. Huizenga NATM, Koper JW, de Lange P, Pols HAP, Stolk RP, Burger H, Grobbee DE, Brinkman AO, de Jong FH, Lamberts SWJ. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998;83:144-151.
52. 2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80.
53. 2-adrenoceptor polymorphism. Thorax 2000;55:762-767.
54. 2-agonist responsiveness to salmeterol [abstract]. Am J Respir Crit Care Med 2004;169:A582.
55. 2-adrenergic receptor genotype in subjects with persistent asthma. Am J Respir Crit Care Med (In press)
56. Tantisira KG, Small KM, Litonjua AA, Weiss ST, Liggett SB. Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase 9 in asthma: interaction between beta-agonist and corticosteroid pathways. Hum Mol Genet 2005;14:1671-1677.